128 related articles for article (PubMed ID: 31066580)
1. Chemical Modeling: From Paul Ehrlich's Dyes to
Travis AS
J Comput Biol; 2019 Jul; 26(7):726-734. PubMed ID: 31066580
[No Abstract] [Full Text] [Related]
2. The return of Ehrlich's 'Therapia magna sterilisans' and other Ehrlich concepts?. Series of papers honoring Paul Ehrlich on the occasion of his 150th birthday.
Sörgel F
Chemotherapy; 2004 Apr; 50(1):6-10. PubMed ID: 15084798
[TBL] [Abstract][Full Text] [Related]
3. Paul Ehrlich's "Mastzellen"--from aniline dyes to DNA chip arrays: a historical review of developments in mast cell research.
Vyas H; Krishnaswamy G
Methods Mol Biol; 2006; 315():3-11. PubMed ID: 16110145
[TBL] [Abstract][Full Text] [Related]
4. Dyes, antipsychotic drugs, and antimicrobial activity. Fragments of a development, with special reference to the influence of Paul Ehrlich.
Kristiansen JE
Dan Med Bull; 1989 Apr; 36(2):178-85. PubMed ID: 2651032
[TBL] [Abstract][Full Text] [Related]
5. Models for biological research: the theory and practice of Paul Ehrlich.
Travis AS
Hist Philos Life Sci; 2008; 30(1):79-97. PubMed ID: 19203012
[TBL] [Abstract][Full Text] [Related]
6. [Not Available].
Hüntelmann AC
Ber Wiss; 2013 Dec; 36(4):354-380. PubMed ID: 33008252
[TBL] [Abstract][Full Text] [Related]
7. Paul Ehrlich's passion: the origins of his receptor immunology.
Silverstein AM
Cell Immunol; 1999 Jun; 194(2):213-21. PubMed ID: 10383824
[TBL] [Abstract][Full Text] [Related]
8. The use of dyes in modern biomedicine.
Wainwright M
Biotech Histochem; 2003; 78(3-4):147-55. PubMed ID: 14714878
[TBL] [Abstract][Full Text] [Related]
9. Rational drug design: a multidisciplinary approach.
Hunter WN
Mol Med Today; 1995 Apr; 1(1):31, 34. PubMed ID: 9415135
[TBL] [Abstract][Full Text] [Related]
10. Paul Ehrlich: pathfinder in cell biology. 1. Chronicle of his life and accomplishments in immunology, cancer research, and chemotherapy.
Kasten FH
Biotech Histochem; 1996 Jan; 71(1):2-37. PubMed ID: 9138526
[TBL] [Abstract][Full Text] [Related]
11. Elie Metchnikoff's and Paul Ehrlich's impact on infection biology.
Kaufmann SH
Microbes Infect; 2008; 10(14-15):1417-9. PubMed ID: 18824243
[TBL] [Abstract][Full Text] [Related]
12. Ahlquist and the development of beta-adrenoceptor antagonists.
Black JW
Postgrad Med J; 1976; 52 Suppl 4():11-13. PubMed ID: 9627
[TBL] [Abstract][Full Text] [Related]
13. [Paul Ehrlich's methods for deciphering the immune defence. One method leads only to an incomplete understanding].
Göing H
Arzneimittelforschung; 2000 Apr; 50(4):404-8. PubMed ID: 10800641
[TBL] [Abstract][Full Text] [Related]
14. Setting the record straight: the origin of the pharmacophore concept.
Güner OF; Bowen JP
J Chem Inf Model; 2014 May; 54(5):1269-83. PubMed ID: 24745881
[TBL] [Abstract][Full Text] [Related]
15. [Introduction of adrenergic beta-blockers into medical therapy].
Varagić VM
Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():1-4. PubMed ID: 18196642
[TBL] [Abstract][Full Text] [Related]
16. The fourth Paul Ehrlich Lecture. Imaging in theory and praxis: from Paul Ehrlich's receptors to modern roentgen analysis.
Karle IL
Med Res Rev; 1992 Jul; 12(4):297-315. PubMed ID: 1326688
[No Abstract] [Full Text] [Related]
17. [Natural dyes and dyeing from the XVIIth century to the birth of synthetic dyes].
Viel C
Rev Hist Pharm (Paris); 2005; 53(347):327-48. PubMed ID: 16358458
[TBL] [Abstract][Full Text] [Related]
18. The early history of the eosinophil.
Kay AB
Clin Exp Allergy; 2015 Mar; 45(3):575-82. PubMed ID: 25544991
[TBL] [Abstract][Full Text] [Related]
19. Paul Ehrlich and the Early History of Granulocytes.
Kay AB
Microbiol Spectr; 2016 Aug; 4(4):. PubMed ID: 27726791
[TBL] [Abstract][Full Text] [Related]
20. Applicable models for multi-component adsorption of dyes: a review.
Noroozi B; Sorial GA
J Environ Sci (China); 2013 Mar; 25(3):419-29. PubMed ID: 23923413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
